Replies to post #43142 on Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

3 other studies that are WIP - NIH, I-SPY and the ZYESAMI Inhaler trial. Still, really bad news for NRXP holders. RLFTF has a larger portfolio of opportunities in the mix, so I see them RLFTF recovering from the upcoming hit much sooner than NRXP. JMHO.